Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Detalles Bibliográficos
Autores principales: Hoch, Jeffrey S., Beca, Jaclyn, Sabharwal, Mona, Livingstone, Scott W., Fields, Anthony L. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519630/
https://www.ncbi.nlm.nih.gov/pubmed/25939500
http://dx.doi.org/10.1007/s40273-015-0278-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519630/
https://www.ncbi.nlm.nih.gov/pubmed/25939500
http://dx.doi.org/10.1007/s40273-015-0278-7

Ejemplares similares